The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
For self-measured BP, smartphone app no better than standard device
Aug 15, 2022
Self-measured blood pressure paired with a connected smartphone app is not superior to standard self-measured blood pressure for blood pressure reduction and patient satisfaction.
Moderna says its booster protects well against omicron
Dec 20, 2021
Experts agree that booster shots are the best defense against the omicron variant of COVID-19.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
Daily step counts still down versus prepandemic levels
Sep 02, 2022
Global variation was seen in recovery, with Europe and North America showing the biggest recovery.
CDC to advise return to masks indoors for some vaccinated Americans
Jul 27, 2021
The latest decision is sharp reversal from one the agency announced just two months ago.
USPSTF: Evidence lacking for screening seniors for visual acuity
Oct 26, 2021
Current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic ≥65s in a primary care setting.
U.S. to buy $1 billion worth of rapid COVID-19 tests
Oct 06, 2021
Many Americans have reported difficulty getting testing appointments or buying at-home tests.
Health care-associated infection up during COVID-19 pandemic
Sep 14, 2021
Increases were seen in national standardized infection ratios for CLABSI, CAUTI, VAE and MRSA bacteremia.
Functionally impaired older adults may use/misuse cannabis, prescription drugs
Jun 03, 2021
A higher risk was seen for medical cannabis use and prescription opioid and tranquilizer/sedative use and misuse.